The current analyst and expert consensus on CVS Health is Buy with 7 hold recommendations. The current projected target price consensus is 89.5 with 18 analysts opinions. One of the most common ways CVS Health analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to CVS Health vendors, executives, and/or customers. CVS Health recommendation module provides expert sentiment on the projected CVS Health target price to derive its highest and lowest estimates based on target price standard deviation of 9.089. Check also Macroaxis Advice on CVS Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.